C9ORF25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.957400E-01
Normal-vs-Stage2
4.558800E-01
Normal-vs-Stage3
5.972400E-02
Normal-vs-Stage4
4.554200E-01
Stage1-vs-Stage2
3.060600E-01
Stage1-vs-Stage3
2.924600E-01
Stage1-vs-Stage4
5.727600E-01
Stage2-vs-Stage3
3.521200E-01
Stage2-vs-Stage4
8.797200E-01
Stage3-vs-Stage4
5.403400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.598600E-01
Normal-vs-AfricanAmerican
1.167760E-01
Normal-vs-Asian
5.754000E-01
Caucasian-vs-AfricanAmerican
3.350400E-01
Caucasian-vs-Asian
8.076400E-01
AfricanAmerican-vs-Asian
7.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.718200E-01
Normal-vs-Female
7.293200E-01
Male-vs-Female
4.004200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.476400E-01
Normal-vs-Age(41-60Yrs)
8.822200E-01
Normal-vs-Age(61-80Yrs)
3.843800E-01
Normal-vs-Age(81-100Yrs)
3.188400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.536400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.988600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.632200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.575200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.768400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.226800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.410100E-02
Normal-vs-Daily Drinker
6.398000E-01
Normal-vs-Weekly Drinker
7.586800E-01
Normal-vs-Occasional Drinker
8.133600E-01
Normal-vs-Social Drinker
6.813600E-01
Non Drinker-vs-Daily Drinker
1.280950E-01
Non Drinker-vs-Weekly Drinker
1.144360E-01
Non Drinker-vs-Occasional Drinker
3.831500E-02
Non Drinker-vs-Social Drinker
4.229900E-02
Daily Drinker-vs-Weekly Drinker
9.438600E-01
Daily Drinker-vs-Occasional Drinker
9.532800E-01
Daily Drinker-vs-Social Drinker
5.164200E-01
Weekly Drinker-vs-Occasional Drinker
8.746400E-01
Weekly Drinker-vs-Social Drinker
4.543200E-01
Occasional Drinker-vs-Social Drinker
4.815400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.089000E-01
Normal-vs-Grade 2
9.559400E-01
Normal-vs-Grade 3
9.352200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.769560E-01
Grade 1-vs-Grade 3
1.310650E-01
Grade 1-vs-Grade 4
8.089000E-01
Grade 2-vs-Grade 3
6.481600E-01
Grade 2-vs-Grade 4
9.559400E-01
Grade 3-vs-Grade 4
9.352200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.984800E-01
Normal-vs-NonDiabetic
7.935200E-01
Diabetic-vs-NonDiabetic
6.740300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.283000E-01
Normal-vs-NoPancreatitis
5.939600E-01
Pancreatitis-vs-NoPancreatitis
7.467200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.550000E-01
Normal-vs-N1
4.971800E-01
N0-vs-N1
4.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.062400E-01
Normal-vs-TP53-NonMutant
1.171230E-01
TP53-Mutant-vs-TP53-NonMutant
1.804790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
